STOCK TITAN

ASAHI KAISEI CRP UNSP/ADR - AHKSY STOCK NEWS

Welcome to our dedicated page for ASAHI KAISEI CRP UNSP/ADR news (Ticker: AHKSY), a resource for investors and traders seeking the latest updates and insights on ASAHI KAISEI CRP UNSP/ADR stock.

Asahi Kasei Corporation (symbol: AHKSY) is a diversified Japanese technology and manufacturing company dedicated to contributing to life and living globally. Since its foundation in 1922 with ammonia and cellulose fiber businesses, Asahi Kasei has continuously transformed its business portfolio to meet evolving market demands. The company operates through three primary sectors: Material, Homes, and Health Care.

In the Material sector, Asahi Kasei produces a wide array of products, including battery separators, biodegradable textiles, engineering plastics, and sound solutions. Recently, the company announced a significant investment in an integrated plant in Ontario, Canada, for manufacturing Hipore™ wet-process lithium-ion battery separators, in partnership with Honda and the Development Bank of Japan.

In the Health Care sector, Asahi Kasei focuses on devices and systems for acute critical care, dialysis, therapeutic apheresis, and the manufacturing of biotherapeutics. The company recently completed the construction of its third assembly plant for Planova™ virus removal filters in Japan and announced the launch of a new plasmid DNA manufacturing facility in Texas, USA, through its subsidiary, Bionova Scientific.

Asahi Kasei is also making strides in the renewable energy sector with its hydrogen business. The company celebrated the opening of a new hydrogen pilot plant in Kawasaki, Japan, marking a significant milestone toward commercializing large-scale alkaline water electrolysis systems for green hydrogen production.

In addition to these advancements, Asahi Kasei is committed to sustainability, aiming to reach carbon neutrality by 2050. The company's R&D initiatives include the development of high ionic conductive electrolytes for lithium-ion batteries, which promise enhanced performance and durability at extreme temperatures.

Asahi Kasei's recent partnership with Axolabs to establish a cutting-edge oligonucleotide cGMP manufacturing facility in Berlin underscores its commitment to innovation in the biopharmaceutical industry. This collaboration aims to accelerate the development and commercialization of oligonucleotide-based therapies to improve patient quality of life globally.

With over 48,000 employees worldwide, Asahi Kasei continues to be a global leader in providing innovative solutions to the world's challenges, ensuring sustainable growth and development.

Rhea-AI Summary

Asahi Kasei Pharma has secured an exclusive license agreement with Chiome Bioscience for their humanized anti-CX3CR1 antibody, currently in preclinical development. This agreement aligns with the company's Open Innovation platform and transformation into a global specialty pharmaceuticals company. The antibody targets CX3CR1, a receptor involved in immune cell migration to inflammatory sites.

The partnership follows Asahi Kasei's recent acquisition of Calliditas Therapeutics, known for TARPEYO™, a therapy for IgA nephropathy. Through their 'One AK Pharma' initiative, which unifies operations in Japan and the U.S., the company aims to achieve $3 billion in annual pharmaceutical sales by 2030, focusing on immunology, transplantation, and related diseases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.85%
Tags
none
-
Rhea-AI Summary

Asahi Kasei's 5th Global Automotive Consumer Survey reveals key insights about customer expectations for fully autonomous vehicles across Japan, China, Germany, and the United States. The survey highlights that car users remain conservative about autonomous technology, with most preferring to retain manual control options and expressing safety concerns.

A silent cabin emerged as the most valued interior feature, with 50% of respondents prioritizing this aspect. This is particularly relevant as 25% of BEV users report excessive noise as their main complaint. The survey indicates that primary activities in autonomous vehicles would be listening to music (56-66% across regions) and passenger conversation, rather than sleeping or working.

Regarding sustainability, Western markets emphasize recyclable materials and sustainable production, while Asian markets focus more on drivetrain technology. Notably, 35% of respondents in Germany and the USA would switch brands for more sustainable options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.85%
Tags
none
-
Rhea-AI Summary

Asahi Kasei has been awarded the 2024 TSMC Excellent Performance Award for its Pimel™ photosensitive Polyimide material, specifically recognizing its excellence in technology collaboration and production support for advanced packaging. The award was presented at TSMC's 2024 Supply Chain Management Forum on December 2, 2024.

Pimel™ is widely used in semiconductor applications including buffer coatings, passivation layers for bumping, and dielectric layers for re-distribution bumping. The company is expanding production capacity with a new Pimel™ plant scheduled to begin operations this fiscal year to meet growing demand in advanced semiconductor manufacturing processes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
none
Rhea-AI Summary

Jiangsu Sailboat Petrochemical has commenced commercial operations of a new carbonates plant in Lianyungang, China, using Asahi Kasei's licensed technology to produce high-purity ethylene carbonate (EC) and dimethyl carbonate (DMC) using CO2 as main feedstock. The plant, which began operations in November 2024, has the capacity to utilize 54,000 tons of CO2 annually to produce 38,000 tons of EC and 70,000 tons of DMC.

These carbonates are essential materials for lithium-ion battery electrolytes used in electric vehicles. The technology implementation stems from a September 2021 license agreement between Asahi Kasei and Sailboat. Including this facility, Asahi Kasei's licensed technology now enables the use of approximately 300,000 tons of CO2 annually as feedstock across various licensees for producing polycarbonate and carbonates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
none
-
Rhea-AI Summary

Asahi Kasei Microdevices (AKM) has begun mass production of its next-generation InAs Hall element, the HQ0A11, featuring the company's smallest and thinnest package size at 0.8 x 0.4 x 0.23 mm. The new product achieves an 85% volume reduction compared to the previous HQ0811 model and offers 16% better signal-to-noise ratio.

The HQ0A11's position detection accuracy is over 3.5 times higher than the GaAs-based HG0C11, making it particularly effective for smartphone camera stabilization and autofocus systems. The device's high-sensitivity InAs compound technology and compact size make it ideal for applications in smartphone cameras, small robots, and other precision devices requiring position detection in spaces.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
none
-
Rhea-AI Summary

Asahi Kasei Battery Separator has broken ground on a new lithium-ion battery separator manufacturing facility in Port Colborne, Ontario. The plant, planned as a joint venture with Honda, is expected to begin commercial production in 2027. The facility will create over 300 full-time jobs and produce approximately 700 million square meters of coated lithium-ion battery separator annually. As Canada's first large-scale wet-process separator facility, it will support the North American electric vehicle market. The company has already begun local hiring and community engagement efforts, with more than five employees currently supporting the project's startup phase.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.27%
Tags
none
Rhea-AI Summary

Asahi Kasei Microdevices (AKM) will showcase advanced sensor technologies at CES 2025 aimed at improving aging-in-place solutions. The company will demonstrate new millimeter-wave radar and contactless monitoring systems that provide AI-ready data while maintaining user privacy. Key innovations include a camera-free fall detection system using antenna-in-module technology, a battery-free smart diaper with moisture detection, and a wristband thermometer featuring the AK9757P sensor. These technologies aim to support the 95% of adults 55 and older who consider aging in place an important goal.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.01%
Tags
AI
-
Rhea-AI Summary

Asahi Kasei and Honda have signed a shareholders' agreement to transform E-Materials Canada into a joint venture for lithium-ion battery separator production. Honda Canada will acquire a 25% stake through new share subscription, with Honda's total investment reaching approximately C$417 million (US$300 million). The joint venture, to be renamed Asahi Kasei Honda Battery Separator , aims to combine both companies' strengths in material and electrification technologies to produce high-quality separators for lithium-ion batteries. Operations are planned to begin in early 2025, subject to regulatory approvals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.01%
Tags
none
-
Rhea-AI Summary

Asahi Kasei Medical has launched Planova™ FG1, a next-generation virus removal filter for biotherapeutics manufacturing, in October 2024. The new filter offers higher flux, approximately 7 times that of Planova™ BioEX, enabling shorter virus filtration time and less risk of virus breakthrough during process suspension. Planova™ FG1 demonstrated high protein filtration and virus removal performance under various conditions, even without a prefilter. It is compatible with standard cleaning and sterilization processes, allowing use with existing biopharmaceutical manufacturing equipment.

Asahi Kasei Medical plans to expand the Planova™ FG1 lineup with larger surface area filters to support efficient process scale-up. The launch aims to solidify the Planova™ brand's presence among biopharmaceutical manufacturers and contribute to safer, more efficient pharmaceutical production as demand for biopharmaceuticals grows by 5-10% annually.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.81%
Tags
none
Rhea-AI Summary

Asahi Kasei, a Japanese technology company, has signed a memorandum of understanding (MOU) with Aquafil S.p.A., an Italian manufacturer of polyamide 6 (PA6), to develop a novel material for 3D printing applications. The collaboration aims to combine Aquafil's ECONYL® Polymer, a chemically recycled PA6, with Asahi Kasei's cellulose nanofiber (CNF).

The resulting compound, in the form of pellets or filaments, offers superior formability and strength, making it suitable for automotive and aeronautical applications. ITOCHU , which has invested in Aquafil, is supporting this initiative. Asahi Kasei plans to begin trial sales of the new compound material's filament in Q3 2025 across the EU, US, and Japan markets.

The innovative material will be showcased at upcoming industry events, including Fakuma, Sustainable Material Expo, and Formnext.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.27%
Tags
none

FAQ

What is the current stock price of ASAHI KAISEI CRP UNSP/ADR (AHKSY)?

The current stock price of ASAHI KAISEI CRP UNSP/ADR (AHKSY) is $13.54 as of December 23, 2024.

What is the market cap of ASAHI KAISEI CRP UNSP/ADR (AHKSY)?

The market cap of ASAHI KAISEI CRP UNSP/ADR (AHKSY) is approximately 10.1B.

What sectors does Asahi Kasei operate in?

Asahi Kasei operates in three primary sectors: Material, Homes, and Health Care.

What recent projects has Asahi Kasei announced?

Recent projects include a new integrated lithium-ion battery separator plant in Canada, a hydrogen pilot plant in Japan, and a plasmid DNA manufacturing facility in Texas, USA.

What is Asahi Kasei's commitment to sustainability?

Asahi Kasei is dedicated to reaching carbon neutrality by 2050 and contributes to sustainable practices across its business sectors.

Who are Asahi Kasei's key partners in recent ventures?

Key partners include Honda in the lithium-ion battery separator project and Axolabs in the oligonucleotide therapeutics manufacturing facility.

What are Asahi Kasei's contributions to the biopharmaceutical industry?

Asahi Kasei contributes through products like Planova™ virus removal filters and by expanding into plasmid DNA manufacturing for new therapeutic modalities.

Where is Asahi Kasei's new hydrogen pilot plant located?

The new hydrogen pilot plant is located in Kawasaki, Japan.

What is the Hipore™ wet-process separator used for?

The Hipore™ wet-process separator is used in lithium-ion batteries for electric vehicles and other energy storage applications.

How does Asahi Kasei support innovation in manufacturing?

Asahi Kasei supports innovation by investing in cutting-edge technologies like high ionic conductive electrolytes for lithium-ion batteries and developing advanced manufacturing equipment.

What are the benefits of Asahi Kasei's high ionic conductive electrolyte?

The high ionic conductive electrolyte allows for increased power output at low temperatures and improved durability at high temperatures, contributing to lower cost and smaller battery packs.

How many employees does Asahi Kasei have globally?

Asahi Kasei employs more than 48,000 people worldwide.

ASAHI KAISEI CRP UNSP/ADR

OTC:AHKSY

AHKSY Rankings

AHKSY Stock Data

10.13B
693.13M
0%
Chemicals
Basic Materials
Link
United States of America
Tokyo